-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Corporation Announces Promising Results from Phase 3 TETON-2 Study of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis at ERS Congress

Reuters·09/12/2025 11:00:25

Please log in to view news